17-Avp-825-301
Research payments
$772,271
Through program year 2021, $772,271 in research payments was reported against 17-Avp-825-301, across 110 payments, paid by Avanir Pharmaceuticals, Inc..
- Paid by
- Avanir Pharmaceuticals, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $3,799 | 1 |
| 2020 | Research | $34,506 | 5 |
| 2019 | Research | $733,966 | 104 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Angel Garcia Sunrise, FL Named on 8 payments
- Joel Saper Ann Arbor, MI Named on 6 payments
- Brian Plato Louisville, KY Named on 5 payments
- Robert Little Phoenix, AZ Named on 5 payments
- Ryan Smith Meridian, ID Named on 4 payments
- John Ervin Kansas City, MO Named on 4 payments
- Michael Pfeffer Miami, FL Named on 4 payments
- Nathan Bennett Pittsburgh, PA Named on 4 payments
- Hossam Abdelsalam Hoffman Estates, IL Named on 4 payments
- Luis Aponte Fort Myers, FL Named on 4 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.